Sandoz Canada Inc.
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Discuss matters related to public funding of pharmaceutical treatments that are developed, manufactured and supplied by Sandoz Canada Inc.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Improve regulatory environment and utilization rates for generics and biosimilars.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|
|
Raising awareness to government officials about the challenge of drug supply in the context of Covid-19 and post-Covid-19.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Health
|
|
Raising awareness to government officials for generic and biosimilar products development by Sandoz Canada Inc. and the potential savings realized by the healthcare system.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Finances and Budgets, Health
|